StenvinkelP., Pecoits-FilhoR., LindholmB.Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem.J Am Soc Nephrol2003; 14: 1927–39.
2.
SzetoC.C., ChowK.M., LamC.W.K., CheungR., KwanB.C.H., ChungK.Y.Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: A prospective cohort study.Perit Dial Int2005; 25: 445–52.
3.
HarrisonD.G.Cellular and molecular mechanisms of endothelial cell dysfunction.J Clin Invest1997; 100: 2153–7.
4.
O'RiordanE., ChenJ., BrodskyS.V., SmirnovaI., LiH., GoligorskyM.S.Endothelial cell dysfunction: The syndrome in making.Kidney Int2005; 67: 1654–8.
5.
van GuldenerC., JanssenM.J., LambertJ., SteynM., DonkerA.J., StehouwerC.D.Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients.Nephrol Dial Transplant1998; 13: 1782–6.
StehouwerC.D., HenryR.M., DekkerJ.M., NijpelsG., HeineR.J., BouterL.M.Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—the Hoorn Study.Kidney Int Suppl2004; 92: S42–4.
8.
SchramM.T., StehouwerC.D.Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome.Horm Metab Res2005; 37(Suppl 1): 49–55.
9.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
10.
Pecoits-FilhoR., StenvinkelP., WangA.Y., HeimburgerO., LindholmB.Chronic inflammation in peritoneal dialysis: The search for the holy grail?Perit Dial Int2004; 24: 327–39.
11.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
12.
HeimbürgerO., WaniewskiJ., WerynskiA., TranaeusA., LindholmB.Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney Int1990; 38: 495–506.
13.
Cueto-ManzanoA.M., Correa-RotterR.Is high peritoneal transport rate an independent risk factor for CAPD mortality?Kidney Int2000; 57: 314–20.
14.
ChungS.H., ChuW.S., LeeH.A., KimY.H., LeeI.S., LindholmB.Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients.Perit Dial Int2000; 20: 541–7.
15.
VoinescuC.G., KhannaR., NolphK.D.High peritoneal transport: A blessing or curse?Adv Perit Dial2002; 18: 106–11.
16.
ChungS.H., HeimburgerO., StenvinkelP., QureshiA.R., LindholmB.Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.Nephrol Dial Transplant2003; 18: 590–7.
17.
Pecoits-FilhoR., CarvalhoM., ChungS.H., Divino FilhoJ., StenvinkelP., HeimbürgerO.Interleukin-6 (IL-6) system and peritoneal solute transport rate: A longitudinal study [Abstract].J Am Soc Nephrol2002; 13: 42A.
18.
LaiK.N., LaiK.B., SzetoC.C., HoK.K., PoonP., LamC.W.Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: Their relationship with transport parameters.Am J Kidney Dis1997; 29: 699–705.
